dalteparin and chondroitin sulfates
dalteparin has been researched along with chondroitin sulfates in 35 studies
Research
Studies (35)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (31.43) | 18.2507 |
2000's | 19 (54.29) | 29.6817 |
2010's | 5 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Herzog, S; Kuhn, W; Rath, W | 1 |
Humphrey, PW; Keller, MP; Kikta, MJ; Silver, D | 1 |
Kwan, YL; Kyle, PW; Manoharan, A; Ramakrishna, R | 1 |
Baker, RI; Gilmore, G; Thom, J | 1 |
Burgess, JK; Chong, BH | 1 |
Peters, FP | 1 |
Wade, WE | 2 |
Horiuchi, M; Ishida, M; Nakada, Y; Sakamoto, F | 1 |
Fernández, JA; Griffin, JH; Petäjä, J | 1 |
Neofotistos, D; Ts'ao, CH; Zmuda, K | 1 |
Barratt, SM; Edwards, RC; Ruff, SJ | 1 |
Keeney, M; Kovacs, MJ | 1 |
Goetschel, P; Leumann, E; Neuhaus, TJ; Schmugge, M | 1 |
Harrison, SJ; McColl, MD; Rafferty, I | 1 |
Gradowski, JF; Martinez, J; San Antonio, JD; Schick, BP | 1 |
Büning, H; Gerner, FM; Hacker, UT; Hallek, M; Hutter, M; Reichenspurner, H; Stangl, M | 1 |
Fujishima, Y; Miyake, Y; Sukamoto, T; Yokota, K | 1 |
Taylor, AA | 1 |
Bonneau, JC; Drouet, M; Gay, G; Le Sellin, J; Leclere, JM; Nicolie, B | 1 |
Counsell, C; Sandercock, P | 1 |
Becker, GJ; McMahon, LP; Polkinghorne, KR | 1 |
Bar, J; Blickstein, D; Hod, M | 1 |
Mitome, J; Yamamoto, H | 1 |
Kossard, S; McGrath, M; Wells, J | 1 |
Asada, M; Ebihara, S; Okazaki, T; Sasaki, H; Takahashi, H; Yamaya, M | 1 |
Cooper, P; Gatt, A; Kitchen, S; Makris, M; van Veen, JJ; Woolley, AM | 1 |
Arvidsson, T; Carlin, G; Ek, M; Hakkarainen, B; McEwen, I; Rundlöf, T | 1 |
Jaussaud, M; Léon, A; Lepouse, C; Murat, O; Perrier, S; Petit, JS | 1 |
Koyama, T | 1 |
Castro-López, V; Hammadi, N; Harris, LF; Killard, AJ; O'Donnell, JS | 1 |
Castro-López, V; Harris, LF; Killard, AJ; O'Donnell, JS | 1 |
Desai, UR; King, JT | 1 |
Bereczky, Z; Boda, Z; Kappelmayer, J; Kerenyi, A; Olah, Z; Szarvas, M | 1 |
Reviews
6 review(s) available for dalteparin and chondroitin sulfates
Article | Year |
---|---|
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
Topics: Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cost-Benefit Analysis; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; MEDLINE; Thrombophlebitis | 1998 |
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Chondroitin Sulfates; Cost-Benefit Analysis; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparinoids; Heparitin Sulfate; Humans; Treatment Outcome; Venous Thrombosis | 1999 |
[Delayed hypersensitivity to heparins and heparinoids].
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Enoxaparin; Female; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Hypersensitivity, Delayed; Nadroparin; Recombinant Proteins; Skin Tests | 2002 |
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Databases, Factual; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Odds Ratio; Pulmonary Embolism; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Venous Thrombosis | 2002 |
[Anticoagulant].
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Benzamidines; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Design; Enoxaparin; Extracorporeal Circulation; Guanidines; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Pipecolic Acids; Protease Inhibitors; Protein C; Recombinant Proteins; Sorption Detoxification; Sulfonamides; Thrombomodulin | 2004 |
[Treatment of disseminated intravascular coagulation].
Topics: Anticoagulants; Antithrombins; Benzamidines; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disseminated Intravascular Coagulation; Gabexate; Guanidines; Heparin; Heparitin Sulfate; Humans; Protease Inhibitors; Protein C; Recombinant Proteins; Thrombomodulin; Tretinoin | 2010 |
Trials
1 trial(s) available for dalteparin and chondroitin sulfates
Article | Year |
---|---|
Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.
Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; Female; Heparinoids; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis | 2002 |
Other Studies
28 other study(ies) available for dalteparin and chondroitin sulfates
Article | Year |
---|---|
[Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Topics: Adult; Anticoagulants; Cesarean Section; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Dose-Response Relationship, Drug; Female; Heparin; Heparitin Sulfate; Humans; Platelet Count; Pre-Eclampsia; Pregnancy; Puerperal Disorders; Thrombocytopenia; Thromboembolism | 1995 |
Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Platelet Aggregation; Thrombocytopenia | 1993 |
Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
Topics: Adult; Aged; Aged, 80 and over; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Interactions; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombocytopenia | 1995 |
Diagnosis of APC resistance in patients on standard or low molecular weight heparin.
Topics: Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Susceptibility; Factor V Deficiency; False Negative Reactions; Heparin; Heparin Lyase; Heparitin Sulfate; Heterozygote; Humans; Partial Thromboplastin Time; Polysaccharide-Lyases; Protein C; Reagent Kits, Diagnostic; Sensitivity and Specificity; Thromboembolism | 1996 |
The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
Topics: Adenosine Diphosphate; Adult; Aged; Anticoagulants; Chondroitin Sulfates; Critical Illness; Dalteparin; Dermatan Sulfate; Drug Synergism; Enoxaparin; Epinephrine; Female; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Intensive Care Units; Male; Middle Aged; Platelet Aggregation; Reference Values | 1997 |
Treatment of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Heparin; Heparinoids; Heparitin Sulfate; Humans; Thrombocytopenia | 1997 |
Ardeparin and danaparoid for prevention of deep vein thrombosis.
Topics: Abdomen; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophlebitis | 1997 |
Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
Topics: Animals; Anticoagulants; Blood Coagulation; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Factor X; Heparin; Heparitin Sulfate; Injections, Intravenous; Male; Rabbits | 1998 |
Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
Topics: Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cattle; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Dextran Sulfate; Drug Synergism; Enoxaparin; Enzyme Activation; Factor V; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Nadroparin; Protein C; Sharks; Structure-Activity Relationship; Swine; Thromboplastin; Tinzaparin | 1999 |
Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
Topics: Antibodies; Anticoagulants; Autoantibodies; Blood Coagulation; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin Lyase; Heparinoids; Heparitin Sulfate; Humans; Partial Thromboplastin Time; Platelet Factor 4; Protamines; Prothrombin Time; Thrombelastography | 2000 |
Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Enoxaparin; Female; Heparitin Sulfate; Humans; Middle Aged; Platelet Count; Radionuclide Imaging; Thrombocytopenia; Warfarin | 2000 |
Inter-assay and instrument variability of anti-Xa--results.
Topics: Anticoagulants; Blood Coagulation Tests; Chondroitin Sulfates; Chromogenic Compounds; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Monitoring; Factor Xa Inhibitors; Heparitin Sulfate; Humans; Reproducibility of Results | 2000 |
Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
Topics: Adolescent; Anticoagulants; Child; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; Kidney Failure, Chronic; Male; Platelet Count; Renal Dialysis; Thrombocytopenia | 2000 |
Management of heparin allergy during pregnancy with danaparoid.
Topics: Adult; Cesarean Section; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Enoxaparin; Factor V; Factor Xa Inhibitors; Female; Gestational Age; Heparitin Sulfate; Heterozygote; Humans; Injections, Subcutaneous; Milk, Human; Mutation; Pregnancy; Venous Thrombosis | 2001 |
Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Binding Sites; Chondroitin Sulfates; Consensus Sequence; Dermatan Sulfate; Drug Design; Enoxaparin; Factor X; Glycosaminoglycans; Heparin; Heparin Antagonists; Heparitin Sulfate; Humans; Mice; Molecular Sequence Data; Peptides; Rats; Thrombin | 2001 |
Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors.
Topics: Anticoagulants; Chondroitin Sulfates; Dependovirus; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Genetic Vectors; HeLa Cells; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Recombinant Proteins; Tinzaparin; Transduction, Genetic | 2001 |
The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
Topics: Animals; Anticoagulants; Antithrombin III; Bleeding Time; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Factor Xa; Factor Xa Inhibitors; Heparin; Heparitin Sulfate; Kinetics; Male; Platelet Aggregation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin | 2001 |
Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
Topics: Adult; Anticoagulants; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Hypersensitivity; Female; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications, Hematologic; Venous Thrombosis | 2001 |
Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
Topics: Adult; Aspirin; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Drug Combinations; Drug Therapy, Combination; Eczema; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pregnancy; Pregnancy Complications | 2003 |
Abdominal wall ulceration and mucinosis secondary to recombinant human interferon-beta-1b.
Topics: Abdominal Wall; Adjuvants, Immunologic; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Female; Fibrinolytic Agents; Heparitin Sulfate; Humans; Injections, Subcutaneous; Interferon beta-1b; Interferon-beta; Middle Aged; Mucinoses; Multiple Sclerosis; Thrombosis; Treatment Outcome; Ulcer | 2005 |
A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity.
Topics: Animals; Anticoagulants; Bleeding Time; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chondroitin Sulfates; Dalteparin; Dermatan Sulfate; Endothelial Cells; Factor X; Gene Expression Regulation, Enzymologic; Glucuronidase; Heparin; Heparitin Sulfate; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; RNA, Messenger; Tumor Burden; Vascular Endothelial Growth Factor A | 2005 |
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Topics: Anticoagulants; Blood Coagulation Factors; Blood Coagulation Tests; Chondroitin Sulfates; Dermatan Sulfate; Drug Interactions; Drug Monitoring; Enoxaparin; Factor VIIa; Factor Xa; Fondaparinux; Heparin; Heparin Antagonists; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; In Vitro Techniques; Partial Thromboplastin Time; Polysaccharides; Protamines; Recombinant Proteins; Thrombin; Tinzaparin | 2008 |
Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.
Topics: Anticoagulants; Calcium; Carbohydrate Sequence; Chondroitin Sulfates; Drug Contamination; Heparin; Magnetic Resonance Spectroscopy; Methylation; Molecular Sequence Data; Nadroparin; Sulfates | 2009 |
[Headaches in a 21-year-old man with Goodpasture disease].
Topics: Anti-Glomerular Basement Membrane Disease; Anticoagulants; Chondroitin Sulfates; Combined Modality Therapy; Dermatan Sulfate; Diabetes Insipidus, Neurogenic; Disseminated Intravascular Coagulation; Enoxaparin; Fatal Outcome; Headache; Heparin; Heparitin Sulfate; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Plasma Exchange; Platelet Factor 4; Sinus Thrombosis, Intracranial; Thrombocytopenia; Young Adult | 2009 |
Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.
Topics: Anticoagulants; Chemistry Techniques, Analytical; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa; Fluorescent Dyes; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Kinetics; Reproducibility of Results; Software; Tinzaparin | 2010 |
Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Fluorescent Dyes; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfonamides; Tinzaparin | 2011 |
Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.
Topics: Amines; Chondroitin Sulfates; Electrophoresis, Capillary; Enoxaparin; Heparin, Low-Molecular-Weight; Molecular Conformation; Polymers | 2011 |
Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
Topics: Anticoagulants; Antithrombins; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Enoxaparin; Factor Xa Inhibitors; False Positive Reactions; Fondaparinux; Heparitin Sulfate; Hirudins; Humans; Lupus Coagulation Inhibitor; Mass Screening; Pipecolic Acids; Polysaccharides; Prothrombin Time; Recombinant Proteins; Sulfonamides; Thrombin | 2013 |